Sitemap
Directory enquiries http://al4a.fun al4a Craig-Hallum Capital analyst Charles Haff initiated coverageof the stock with a "buy" rating, saying the company's revenuewould triple by 2015 as its lead experimental drug would beadopted by dialysis pr…